Health In Tech (NASDAQ:HIT) Cut to Buy at Wall Street Zen

Wall Street Zen cut shares of Health In Tech (NASDAQ:HIT - Free Report) from a strong-buy rating to a buy rating in a report issued on Saturday.

Separately, Maxim Group raised shares of Health In Tech to a "strong-buy" rating and set a $2.50 price target for the company in a research report on Thursday, June 26th.

Health In Tech Stock Performance

Shares of HIT traded up $0.04 during trading hours on Friday, reaching $1.09. 266,663 shares of the stock traded hands, compared to its average volume of 1,203,050. Health In Tech has a 52-week low of $0.51 and a 52-week high of $7.59. The company's 50-day simple moving average is $0.72.

Health In Tech (NASDAQ:HIT - Get Free Report) last issued its quarterly earnings data on Monday, April 14th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). The company had revenue of $8.02 million for the quarter, compared to the consensus estimate of $6.87 million.

Institutional Investors Weigh In On Health In Tech

Several institutional investors have recently bought and sold shares of the company. XTX Topco Ltd acquired a new stake in Health In Tech in the first quarter valued at approximately $59,000. Jane Street Group LLC purchased a new stake in shares of Health In Tech during the first quarter valued at approximately $48,000. Arete Wealth Advisors LLC acquired a new position in Health In Tech in the first quarter worth $47,000. Finally, Cubist Systematic Strategies LLC acquired a new stake in Health In Tech in the first quarter worth about $41,000.

About Health In Tech

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.